Table 2.

Summary of factors identified to drive biosimilar use and facilitate biosimilar acceptance in Germany. These factors have been identified through the qualitative analysis of interview data.

Drivers of Biosimilar Use	Factors Facilitating Biosimilar Acceptance
Biosimilar prescription quotas:   -Efficient monitoring   -Presence of a sanctioning mechanism	Efficient communication between stakeholders   -Robust reporting capability of regional   physician associations
Greater cost-savings potential associated to biosimilars
Gainsharing contracts
Position statements/guidelines on the safety of switching